Study to Evaluate the Tolerance and Safety of a Peptide-based Enteral Formula with Partially Hydrolyzed Guar Gum (PHGG)
Public ClinicalTrials.gov record NCT04516213. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Single-arm Study to Evaluate the Tolerance and Safety of a Peptide-based Enteral Formula with Partially Hydrolyzed Guar Gum (PHGG) in the Nutritional Management of Tube-fed Children Aged 1-4 Years.
Study identification
- NCT ID
- NCT04516213
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Société des Produits Nestlé (SPN)
- Industry
- Enrollment
- 24 participants
Conditions and interventions
Conditions
Interventions
- Enteral Formula With (PHGG) Other
Other
Eligibility (public fields only)
- Age range
- 1 Year to 4 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 27, 2020
- Primary completion
- May 31, 2021
- Completion
- May 31, 2021
- Last update posted
- Oct 14, 2024
2020 – 2021
United States locations
- U.S. sites
- 5
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Center for GI and Nutrition | Hollywood | Florida | 33021 | — |
| The University of Chicago Medicine | Chicago | Illinois | 60637 | — |
| Riley Children's Hospital | Indianapolis | Indiana | 46202 | — |
| The Children's Mercy Hospital | Kansas City | Missouri | 64108 | — |
| University of Utah Health Care - Huntsman Cancer Institute (HCI) | Salt Lake City | Utah | 84113-1125 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04516213, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 14, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04516213 live on ClinicalTrials.gov.